Following piloted FX activity, Krytheon advances toward point-of-sale deployment across a 23-country carrier and its ...
The market is viewing NVIDIA's decision to keep its 7.7 million share stake in Recursion while divesting from other AI holdings as a significant strategic move. This decision indicates NVIDIA's ...
Recursion claims that its artificial-intelligence-backed drug discovery platform gets smarter each time it pinpoints a new drug candidate—which is why, even with several of those candidates already in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results